Aclaris Therapeutics, Inc

Avalo Therapeutics, Inc. is a clinical-stage biotechnology company headquartered in Rockville, MD, focused on developing novel IL-1-based therapies for immune-mediated inflammatory diseases. Their lead candidate, AVTX-009, is currently undergoing Phase 2 clinical trials aimed at treating hidradenitis suppurativa (HS), alongside exploring additional opportunities to address unmet medical needs in prevalent indications. Committed to advancing an inspired pipeline, Avalo emphasizes an innovative approach to next-generation treatments targeting the IL-1 pathway. The company aims to make a significant impact in the field of inflammation and is dedicated to fostering a rewarding career environment for its team members. Generated from the website

QR Pharma Inc is a pharmaceutical company based in Berwyn, PA, specializing in the research and development of innovative treatments for neurodegenerative diseases. The company is dedicated to advancing scientific discoveries to address the unmet medical needs of patients suffering from conditions such as Alzheimer's disease and Parkinson's disease. Generated from their business information